GMP Cytokines Market: Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
According to our new research study on “GMP Cytokines Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, and Application,” the market is expected to reach US$ 158.13 million in 2027 from US$ 84.72 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights trends prevailing in the global GMP cytokines market and factors governing the market growth.
GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
Get sample Research on GMP Cytokines Market at: https://www.theinsightpartners.com/sample/TIPRE00008212/
GMP Cytokines Market Competitive Landscape
Miltenyi Biotec; Sino Biological Inc.; ABCAM; PeproTech Inc.; Akron Biotech; CellGenix GmbH; BIO-TECHNE CORPORATION; CREATIVE BIOARRAY; Proteintech Group, Inc.; and REPROCELL Inc. are among the leading companies operating in the GMP cytokines market.
The growth of the GMP cytokines market is mainly attributed to the increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.
Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.
Near Infrared Imaging Market Segmentation Review
GMP Cytokines Market Segmentation Review
Based on type, the growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is expected to grow at the fastest CAGR during the forecast period. TNF-α is cytotoxic to a wide range of tumor cells, and is a vital factor in stimulating immune response against bacterial infections. Increasing prevalence of cancer and infectious diseases is likely to propel the growth of the segment. Additionally, an extensive research study on TNF is likely to favor the growth of the segment during the forecast period. For instance, ‘Nonconventional induction strategies for production of recombinant human tumor necrosis factor-alpha in Escherichia coli’ was published in 2018.
Based on application, the GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
GMP Cytokines Market – by Geography
- North America
- Rest of Europe
- Asia Pacific (APAC)
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East and Africa
- South and Central America
- Rest of South and Central America
Buy Complete Report of GMP Cytokines Market at: https://www.theinsightpartners.com/buy/TIPRE00008212/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us: